MedTrace Logo

Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy

NCT06277453 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 219

Last updated 2024-02-26

No results posted yet for this study

Summary

To explore the effect of adjuvant chemotherapy cycles on the prognosis of this specific patient with lymph node-negative gastric cancer following neoadjuvant chemotherapy.

Conditions

  • Locally Advanced Gastric Cancer

Interventions

OTHER

surgery

radical gastric cancer surgery (R0) and D2 lymph node dissection

Sponsors & Collaborators

  • Fujian Medical University

    lead OTHER

Principal Investigators

  • Chang-Ming Huang · Fujian Medical University Union Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-08-25
Completion
2024-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06277453 on ClinicalTrials.gov